These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25307213)

  • 1. P-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery.
    Davis TP; Sanchez-Covarubias L; Tome ME
    Adv Pharmacol; 2014; 71():25-44. PubMed ID: 25307213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia.
    McCaffrey G; Staatz WD; Sanchez-Covarrubias L; Finch JD; Demarco K; Laracuente ML; Ronaldson PT; Davis TP
    J Neurochem; 2012 Sep; 122(5):962-75. PubMed ID: 22716933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Regulation Mechanisms of P-gp in the Blood-Brain Barrier in Hypoxia.
    Ding Y; Wang R; Zhang J; Zhao A; Lu H; Li W; Wang C; Yuan X
    Curr Pharm Des; 2019; 25(10):1041-1051. PubMed ID: 31187705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug delivery.
    McCaffrey G; Davis TP
    J Investig Med; 2012 Dec; 60(8):1131-40. PubMed ID: 23138008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abundance of P-Glycoprotein and Other Drug Transporters at the Human Blood-Brain Barrier in Alzheimer's Disease: A Quantitative Targeted Proteomic Study.
    Storelli F; Billington S; Kumar AR; Unadkat JD
    Clin Pharmacol Ther; 2021 Mar; 109(3):667-675. PubMed ID: 32885413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models.
    Liu Q; Hou J; Chen X; Liu G; Zhang D; Sun H; Zhang J
    PLoS One; 2014; 9(7):e102442. PubMed ID: 25036090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model.
    Chan GN; Evans RA; Banks DB; Mesev EV; Miller DS; Cannon RE
    Neurosci Lett; 2017 Feb; 639():103-113. PubMed ID: 28011392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in P-glycoprotein levels in the blood-brain barrier of partial portal vein ligation /chronic hyperammonemia rats is medicated by ammonia/reactive oxygen species/ERK1/2 activation: In vitro and in vivo studies.
    Zhou Y; Zhou J; Li P; Xie Q; Sun B; Li Y; Chen Y; Zhao K; Yang T; Zhu L; Xu J; Liu X; Liu L
    Eur J Pharmacol; 2019 Mar; 846():119-127. PubMed ID: 30639310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein traffics from the nucleus to the plasma membrane in rat brain endothelium during inflammatory pain.
    Tome ME; Herndon JM; Schaefer CP; Jacobs LM; Zhang Y; Jarvis CK; Davis TP
    J Cereb Blood Flow Metab; 2016 Nov; 36(11):1913-1928. PubMed ID: 27466374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic morphine exposure potentiates p-glycoprotein trafficking from nuclear reservoirs in cortical rat brain microvessels.
    Schaefer CP; Arkwright NB; Jacobs LM; Jarvis CK; Hunn KC; Largent-Milnes TM; Tome ME; Davis TP
    PLoS One; 2018; 13(2):e0192340. PubMed ID: 29414996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavir.
    Roy U; Bulot C; Honer zu Bentrup K; Mondal D
    PLoS One; 2013; 8(10):e75374. PubMed ID: 24098380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute pain alters P-glycoprotein-containing protein complexes in rat cerebral microvessels: Implications for P-glycoprotein trafficking.
    Tome ME; Jarvis CK; Schaefer CP; Jacobs LM; Herndon JM; Hunn KC; Arkwright NB; Kellohen KL; Mierau PC; Davis TP
    J Cereb Blood Flow Metab; 2018 Dec; 38(12):2209-2222. PubMed ID: 30346224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Clioquinol on P-glycoprotein Expression and Biometal Distribution in the Mouse Brain Microvasculature.
    McInerney MP; Pan Y; Volitakis I; Bush AI; Short JL; Nicolazzo JA
    J Pharm Sci; 2019 Jul; 108(7):2247-2255. PubMed ID: 30738852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.
    Elsinga PH; Hendrikse NH; Bart J; Vaalburg W; van Waarde A
    Curr Pharm Des; 2004; 10(13):1493-503. PubMed ID: 15134571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia increases expression of selected blood-brain barrier transporters GLUT-1, P-gp, SLC7A5 and TFRC, while maintaining barrier integrity, in brain capillary endothelial monolayers.
    Ozgür B; Helms HCC; Tornabene E; Brodin B
    Fluids Barriers CNS; 2022 Jan; 19(1):1. PubMed ID: 34983574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenac.
    Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Zhang Y; Laracuente ML; DeMarco KM; Ronaldson PT; Davis TP
    PLoS One; 2014; 9(2):e88516. PubMed ID: 24520393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function
    Patel S; Leibrand CR; Palasuberniam P; Couraud PO; Weksler B; Jahr FM; McClay JL; Hauser KF; McRae M
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier.
    Zhou ZW; Chen X; Liang J; Yu XY; Wen JY; Zhou SF
    Drug Metab Lett; 2007 Aug; 1(3):205-17. PubMed ID: 19356045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the efflux transporter, P-glycoprotein, at the blood-brain barrier in drug discovery.
    Cox B; Nicolaï J; Williamson B
    Biopharm Drug Dispos; 2023 Feb; 44(1):113-126. PubMed ID: 36198662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins.
    Jodoin J; Demeule M; Fenart L; Cecchelli R; Farmer S; Linton KJ; Higgins CF; Béliveau R
    J Neurochem; 2003 Nov; 87(4):1010-23. PubMed ID: 14622130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.